Table 4 Multivariable regression models estimating association of study variables with all-cause mortality and lung cancer mortality
From: Prognosis in HIV-infected patients with non-small cell lung cancer
Characteristic | Hazard ratio for all-cause mortality a | 95% CI | Odds ratio for lung cancer mortality b | 95% CI |
|---|---|---|---|---|
HIV infection | 1.9 | 1.6–2.2 | 1.7 | 1.1–2.3 |
Age (10 years) | 1.2 | 1.0–1.4 | 1.3 | 1.1–1.4 |
Female | 0.6 | 0.5–0.7 | 0.4 | 0.3–0.6 |
Race/ethnicity | ||||
Whitec | –– | –– | ||
African–American | 1.0 | 0.9–1.1 | 0.9 | 0.7–1.2 |
Hispanic | 1.0 | 0.8–1.2 | 0.8 | 0.5–1.3 |
Other | 1.1 | 0.9–1.3 | 1.0 | 0.7–1.6 |
Married | 0.8 | 0.7–0.9 | 0.6 | 0.5–0.8 |
Income in zip code of residence above median | 0.8 | 0.7–0.9 | 0.8 | 0.6–1.1 |
Nursing home resident | 1.4 | 1.2–1.8 | 1.5 | 0.9–2.4 |
Home medical services | 1.0 | 0.7–1.3 | 0.4 | 0.2–0.7 |
Disability or end-stage renal disease as reason for medicare entitlement | 0.9 | 0.8–1.1 | 0.7 | 0.5–1.1 |
Modified Charlson comorbidity score | 1.2 | 1.1–1.2 | 1.4 | 1.3–1.6 |
Tumour stage | ||||
Ic | –– | –– | ||
II | 1.2 | 0.9–1.6 | 1.7 | 1.0–2.9 |
IIIA | 1.6 | 1.3–1.9 | 2.9 | 1.9–4.3 |
IIIB | 3.4 | 2.8–4.0 | 9.9 | 6.7–14.6 |
IV | 5.7 | 4.8–6.7 | 20.8 | 14.6–29.7 |
Stage-appropriate treatment | 0.5 | 0.4–0.6 | 0.4 | 0.3–0.6 |
Year of cancer diagnosis | ||||
1996–1999c | –– | –– | ||
2000–2003 | 1.0 | 0.8–1.2 | 0.8 | 0.6–1.2 |
2004–2007 | 0.9 | 0.8–1.1 | 0.2 | 0.1–0.2 |
